Pediatric Nephrology

, Volume 30, Issue 4, pp 541–548 | Cite as

Renal transplantation in human immunodeficiency virus (HIV)-positive children

Review

Abstract

Renal transplantation is being performed in adult human immunodeficiency virus (HIV)-positive patients and increasingly in paediatric patients as well. A multidisciplinary team involving an infectious disease professional is required to assist with HIV viral-load monitoring and in choosing the most appropriate highly active antiretroviral therapy (HAART). Drug interactions complicate immunosuppressant therapy and require careful management. The acute rejection rates appear to be similar in adults to those in noninfective transplant recipients. Induction with basiliximab and calcineurin-based immunosuppression appears to be safe and effective in these recipients. Prophylaxis is advised for a variety of infections and may need life-long administration, especially in children. Organ shortage remains a significant problem, and kidneys from deceased HIV-positive donors have been used successfully in a small study population. Overall, with careful planning and close follow-up, successful renal transplantation for paediatric HIV-infected recipients is possible.

Keywords

Paediatric HIV-infected renal transplantation Acute kidney injury HAART Immunosuppression 

Supplementary material

467_2014_2782_MOESM1_ESM.pptx (1.9 mb)
Figure S1Histology Slides (PPTX 1994 kb)

References

  1. 1.
    Czech LA (2010) Tackling the Unknowns in HIV-Related Kidney Disease. N Engl J Med 363:2058–2059CrossRefGoogle Scholar
  2. 2.
    Abbott KC, Swanson SJ, Agodoa LYC, Kimmel PL (2004) Human Immunodeficiency Virus Infection and Kidney Transplantation in the Era of Highly Active Antiretroviral Therapy and Modern Immunosuppression. J Am Soc Nephrol 15:1633–1639CrossRefPubMedGoogle Scholar
  3. 3.
    Kuok PC, Stock PG (2001) Transplantation in the HIV-infected patient. Am J Transplant 1:13–17CrossRefGoogle Scholar
  4. 4.
    Gow PJ, Pillay D, Mutimer D (2001) Solid organ transplantation in patients with HIV infection. Transplantation 72:177–181CrossRefPubMedGoogle Scholar
  5. 5.
    WHO Global Health Observatory – Map Gallery http://gamapserver.who.int/maplibrary (accessed on 26/08/2013)
  6. 6.
    WHO guidelines website www.who.int/hiv/publ/guidelines (accessed on 26/08/2013)
  7. 7.
    Katz IJ, Gerntholtz T, Naicker S (2010) Africa and Nephrology: The Forgotten Continent. Nephron Clin Pract 117:c320–c327CrossRefPubMedGoogle Scholar
  8. 8.
    Arendse C, Wearne N, Okpechi I, Swanepoel C (2010) The acute, the chronic and the news of HIV-related renal disease in Africa. Kidney Int 78:239–245CrossRefPubMedGoogle Scholar
  9. 9.
    Karpelowsky JS, Leva E, Kelley B, Numanoglu A, Rode H, Millar AJ (2009) Outcomes of HIV-infected and –exposed children undergoing surgery – a prospective study. J Pediatr Surg 44:681–687CrossRefPubMedGoogle Scholar
  10. 10.
    Kopp JB, Winkler CA, Nelson GW (2010) MYH9 Genetic Variants Associated with Glomerular Disease: What is the Role for Genetic Testing? Semin Nephrol 30:409–417CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Genovese G, Friedman DJ, Ross MD, Lecordier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Knob AU, Bernhardy AJ, Hicks PJ, Nelson GW, Vanhollebeke B, Winkler CA, Kopp JB, Pays E, Pollak MR (2010) Association of Trypanolytic ApoL1 variants with Kidney Disease in African-Americans. Science 329:841–845CrossRefPubMedCentralPubMedGoogle Scholar
  12. 12.
    Genovese G, Friedman DJ, Pollak MR (2013) APOL1 variants and kidney disease in people of recent African ancestry. Nat Rev Nephrol 9:240–244CrossRefPubMedGoogle Scholar
  13. 13.
    Bickel M, Marben W, Betz C, Khaykin P, Stephan C, Gute P, Harberl A, Knecht G, Wolf T, Brodt HR, Geiger H, Herrmann E, Jung O (2013) End-stage renal disease and dialysis in HIV-positive patients: observations from a long-term cohort study with a follow-up of 22 years. HIV Med 14:127–135CrossRefPubMedGoogle Scholar
  14. 14.
    McCulloch MI, Ray PE (2008) Kidney Disease in HIV-positive children. Semin Nephrol 28:585–594CrossRefPubMedCentralPubMedGoogle Scholar
  15. 15.
    Smart T (2011) Kidney Disease in people with HIV: a clinical review. HATiP 171:1–8Google Scholar
  16. 16.
    Bruggeman LA, Nelson PJ (2009) Controversies in the pathogenesis of HIV-associated renal diseases. Nat Rev Nephrol 5:574–581CrossRefPubMedCentralPubMedGoogle Scholar
  17. 17.
    Foy MC, Estrella MM, Lucas GM, Tahir F, Fine DM, Moore RD, Atta MG (2013) Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy. Clin J Am Soc Nephrol 8:1524–1532CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Rao TK, Filippone EJ, Nicastri AD, Landesman SH, Frank E, Chen CK, Friedman EA (1987) Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N Engl J Med 321:669–673Google Scholar
  19. 19.
    Strauss J, Abitbol C, Zilleruelo G, Scott G, Paredes A, Malaga S, Montané B, Mitchell C, Parks W, Pardo V (1989) Renal disease in children with the acquired immunodeficiency syndrome. N Engl J Med 321:625–630CrossRefPubMedGoogle Scholar
  20. 20.
    Gerntholtz TE, Goetsch SJ, Katz I (2006) HIV-related nephropathy: a South African perspective. Kidney Int 69:1885–1891CrossRefPubMedGoogle Scholar
  21. 21.
    Booth JW, Connolly JO (2011) Managing renal disease in HIV-positive patients. Br J Renal Med 16:19–23Google Scholar
  22. 22.
    Ray PE, Xu L, Rakusan T, Liu XH (2004) A 20 year history of childhood HIV associated nephropathy. Pediatr Nephrol 19:1075–1079CrossRefPubMedGoogle Scholar
  23. 23.
    Estrella MM, Fine DM (2010) Screening for Chronic Kidney Disease in HIV-infected Patients. Adv Chronic Kidney Dis 17:26–35CrossRefPubMedCentralPubMedGoogle Scholar
  24. 24.
    Anochie IC, Eke FU, Okpere AN (2008) Human immunodeficiency virus-associated nephropathy (HIVAN) in Nigerian children. Pediatr Nephrol 23:117–122CrossRefPubMedGoogle Scholar
  25. 25.
    Esezobor CI, Iroha E, Onifade E, Akinsulie AO, Temiye EO, Ezeaka C (2010) Prevalence of proteinuria among HIV-infected children attending a tertiary hospital in Lagos, Nigeria. J Trop Pediatr 56:187–190CrossRefPubMedGoogle Scholar
  26. 26.
    Mistry BJ, Kala UK (2010) Relevance of microalbuminuria in screening for HIV-associated nephropathy. Pediatr Nephrol 25:1870.23Google Scholar
  27. 27.
    Ramsuran D, Bhimma R, Ramdial PK, Naicker E, Adhikari M, Deonarain J, Sing Y, Naicker T (2012) The spectrum of HIV-related nephropathy in children. Pediatr Nephrol 27:821–827CrossRefPubMedGoogle Scholar
  28. 28.
    Nourse PJ, Cotton MF, Bates WD (2010) Renal Manifestations in children co-infected with HIV and disseminated tuberculosis. Pediatr Nephrol 25:1759–1763CrossRefPubMedGoogle Scholar
  29. 29.
    Paragas N, Nickolas TL, Wyatt C, Forster CS, Sise M, Morgello S, Jagla B, Buchen C, Stella P, Sanna-Cherchi S, Carnevali ML, Mattei S, Bovino A, Argentiero L, Magnano A, Devarajan P, Schmidt-Ott KM, Allegri L, Klotman P, D’Agati V, Gharavi AG, Barasch J (2009) Urinary NGAL marks cystic disease in HIV-associated nephropathy. J Am Soc Nephrol 20:1687–1692CrossRefPubMedCentralPubMedGoogle Scholar
  30. 30.
    Sola-Del Valle DA, Mohan S, Cheng JT, Paragas NA, Sise ME, D’Agati VD, Barasch J (2011) Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy. Nephrol Dial Transplant 26:2387–2390CrossRefPubMedCentralPubMedGoogle Scholar
  31. 31.
    Soler-Garcia AA, Johnson D, Hathout Y, Ray PE (2009) Iron-related proteins: candidate urine biomarkers in childhood HIV-associated renal diseases. Clin J Am Soc Nephrol 4:337–344CrossRefGoogle Scholar
  32. 32.
    Landrø L, Damås JK, Flo TH, Heggelund L, Ueland T, Tjønnfjord GE, Espevik T, Aukrust P, Frøland SS (2008) Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected: increase during highly active anti-retroviral therapy. Clin Exp Immunol 152:57–63CrossRefPubMedCentralPubMedGoogle Scholar
  33. 33.
    Soler-Garcia ÁA, Rakhmanina NY, Mattison PC, Ray PE (2009) A urinary biomarker profile for children with HIV-associated renal diseases. Kidney Int 76:207–214CrossRefPubMedCentralPubMedGoogle Scholar
  34. 34.
    Kinae E, Hanabusa H (2005) Renal tubular toxicity associated with Tenofovir assessed using urine-beta 2 microglobulin, percentage of tubular reabsorption of phosphate and alkaline phosphatase levels. AIDS 19:2031–2033CrossRefGoogle Scholar
  35. 35.
    Trullas JC, Cofan F, Tuset M, Ricart MJ, Brunet M, Cervera C, Manzardo C, Lopez-Dieuez M, Oppenheimer F, Moreno A, Campistol JM, Miro JM (2011) Renal Transplantation in HIV-infected patients:2010 update. Kidney Int 79:825–842CrossRefPubMedGoogle Scholar
  36. 36.
    Mazuecos A, Benot R, Moreno A, Burgos D, Aguera M, Alvarez GT, Hernandez D, Navarro D, Castro P (2012) Renal Replacement Therapy in patients with HIV infection in a European Region: Outcomes following Renal Transplantation. Transplant Proc 44:2053–2056CrossRefPubMedGoogle Scholar
  37. 37.
    Stock PG, Barin B, Murphy B, Hanto D, Diego JM, Light J, Davis C, Blumberg E, Simon D, Subramanian A, Millis JM, Lyon GM, Brayman K, Slakey D, Shapiro R, Melancon J, Jacobson JM, Stosor V, Olson JL, Stablein DM, Roland ME (2010) Outcomes of Kidney Transplantation in HIV-Infected Recipients. N Engl J Med 363:2004–2014CrossRefPubMedCentralPubMedGoogle Scholar
  38. 38.
    Mazuecos A, Fernandez A, Andres A, Gomez E, Zarraga S, Burgos D, Jimenez C, Paul J, Rodriguez-Benot A, Fernandez C (2011) HIV infection and renal transplantation. Nephrol Dial Transplant 26:1401–1407CrossRefPubMedGoogle Scholar
  39. 39.
    Touzot M, Pillebout E, Matignon M, Tricot L, Viard JP, Rondeau E, Legendre C, Glotz D, Delahousse M, Lang P, Peraldi MN (2010) Renal Transplantation in HIV-infected Patients: The Paris Experience. Am J Transplant 10:2263–2269CrossRefPubMedGoogle Scholar
  40. 40.
    Frasetto LA, Browne M, Cheng Frassetto LA, Browne M, Cheng A, Wolfe AR, Roland ME, Stock PG, Carlson L, Benet LZ (2007) Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 7:2816–2820CrossRefGoogle Scholar
  41. 41.
    Tricot L, Teicher E, Peytavin G, Zucman D, Conti F, Calmus Y, Barrou B, Duvivier C, Fontaine C, Welker Y, Billy C, de Truchis P, Delahousse M, Vittecoq D, Salmon-Céron D (2009) Safety and Efficacy of Raltegravir in HIV-infected transplant patients co-treated with immunosuppressive drugs. Am J Transplant 9:1946–1952CrossRefPubMedGoogle Scholar
  42. 42.
    Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, Tashima KT, Roland M, Franceschini N, Palella FJ, Lennox JL, Klotman PE, Nachman SA, Hall SD, Szczech LA (2005) Guidelines for the management of chronic kidney disease in HIV-infected patients: Recommendations of the HIV medicine association of the Infectious Diseases society of America. Clin Infect Dis 40:1559–1585CrossRefPubMedGoogle Scholar
  43. 43.
    Izzedine H, Harris M, Perazella MA (2009) The nephrotoxic effects of HAART. Nat Rev Nephrol 5:563–573CrossRefPubMedGoogle Scholar
  44. 44.
    Labarga P, Barreiro P, Martin-Carbonero L, Rodriguez-Novoa S, Solera C, Medrano J, Rivas P, Albalater M, Blanco F, Moreno V, Vispo E, Soriano V (2009) Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with Tenofovir. AIDS 23:689–696CrossRefPubMedGoogle Scholar
  45. 45.
    Mohan S, Herlitz LC, Tan J, Cheng JT, Anderson HL, Stokes MB, Markowitz GS, D'Agati VD, Radhakrishnan J (2010) Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological and mitochondrial abnormalities. Kidney Int 78:1171–1177CrossRefPubMedGoogle Scholar
  46. 46.
    Moosa MR (2005) Kaposi’s sarcoma in kidney transplant recipients: a 23-year experience. QJM 98:205–214CrossRefPubMedGoogle Scholar
  47. 47.
    Weber S, Tönshoff B (2005) Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects. Transplantation 80(1 Suppl):S128–S134CrossRefPubMedGoogle Scholar
  48. 48.
    Kotton CN (2010) Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol 6:711–721CrossRefPubMedGoogle Scholar
  49. 49.
    Muller E, Kahn D, Mendelson M (2010) Renal Transplantation between HIV-positive Donors and Recipients. N Engl J Med 362:2336–2337CrossRefPubMedGoogle Scholar
  50. 50.
    Singh JA (2010) Organ transplantation between HIV-infected patients. Lancet 375:442–443CrossRefPubMedGoogle Scholar
  51. 51.
    Rao TK, Friedman EA, Nicastri AD (1987) The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med 316:1062–1068CrossRefPubMedGoogle Scholar

Copyright information

© IPNA 2014

Authors and Affiliations

  1. 1.Department of Paediatrics, Red Cross Children’s HospitalUniversity of Cape TownCape TownSouth Africa
  2. 2.Department of Paediatrics, Chris Hani Baragwanath Academic HospitalUniversity of WitwatersrandJohannesburgSouth Africa

Personalised recommendations